PD-1 and TIGIT coexpression identifies a circulating CD8 T cell subset predictive of response to anti-PD-1 therapy

Abstract

Our results provide a convincing rationale for monitoring this PD-1⁺TIGIT⁺ circulating population as an early cellular-based marker of therapeutic response to anti-PD-1 therapy.